Latest Insider Transactions at Amgen Inc (AMGN)
This section provides a real-time view of insider transactions for Amgen Inc (AMGN). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of AMGEN INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of AMGEN INC's insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Apr 27
2018
|
Anthony C Hooper EVP, Global Commercial Ops. |
BUY
Grant, award, or other acquisition
|
Direct |
4,508
+2.04%
|
-
|
Apr 27
2018
|
Lori A Johnston EVP, HR |
BUY
Grant, award, or other acquisition
|
Direct |
2,028
+10.61%
|
-
|
Apr 27
2018
|
David W Meline EVP & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
4,508
+6.97%
|
-
|
Apr 27
2018
|
Cynthia M Patton SVP & CCO |
BUY
Grant, award, or other acquisition
|
Direct |
901
+3.57%
|
-
|
Apr 27
2018
|
David Piacquad SVP, Business Development |
BUY
Grant, award, or other acquisition
|
Direct |
957
+2.54%
|
-
|
Apr 27
2018
|
Esteban Santos EVP, Operations |
BUY
Grant, award, or other acquisition
|
Direct |
3,155
+7.93%
|
-
|
Apr 25
2018
|
David Piacquad SVP, Business Development |
SELL
Payment of exercise price or tax liability
|
Direct |
217
-0.6%
|
$37,107
$171.94 P/Share
|
Apr 12
2018
|
Sean E Harper EVP, Research & Development |
SELL
Open market or private sale
|
Direct |
1,525
-2.62%
|
$262,300
$172.68 P/Share
|
Mar 23
2018
|
Robert A Bradway Chairman, CEO and President |
SELL
Payment of exercise price or tax liability
|
Direct |
25,666
-5.77%
|
$4,517,216
$176.08 P/Share
|
Mar 23
2018
|
Sean E Harper EVP, Research & Development |
SELL
Payment of exercise price or tax liability
|
Direct |
7,549
-11.46%
|
$1,328,624
$176.08 P/Share
|
Mar 23
2018
|
Anthony C Hooper EVP, Global Commercial Ops. |
SELL
Payment of exercise price or tax liability
|
Direct |
8,807
-4.0%
|
$1,550,032
$176.08 P/Share
|
Mar 23
2018
|
David W Meline EVP & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
7,549
-11.95%
|
$1,328,624
$176.08 P/Share
|
Mar 23
2018
|
Cynthia M Patton SVP & CCO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,257
-5.09%
|
$221,232
$176.08 P/Share
|
Mar 23
2018
|
David Piacquad SVP, Business Development |
SELL
Payment of exercise price or tax liability
|
Direct |
1,519
-4.05%
|
$267,344
$176.08 P/Share
|
Mar 23
2018
|
Esteban Santos EVP, Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
1,634
-4.65%
|
$287,584
$176.08 P/Share
|
Mar 16
2018
|
Sean E Harper EVP, Research & Development |
SELL
Open market or private sale
|
Direct |
1,525
-2.27%
|
$288,225
$189.75 P/Share
|
Mar 07
2018
|
Robert A Bradway Chairman, CEO and President |
BUY
Grant, award, or other acquisition
|
Direct |
51,404
+10.37%
|
-
|
Mar 07
2018
|
Sean E Harper EVP, Research & Development |
BUY
Grant, award, or other acquisition
|
Direct |
15,118
+18.36%
|
-
|
Mar 07
2018
|
Anthony C Hooper EVP, Global Commercial Ops. |
BUY
Grant, award, or other acquisition
|
Direct |
17,638
+7.42%
|
-
|
Mar 07
2018
|
David W Meline EVP & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
15,118
+19.37%
|
-
|
Mar 07
2018
|
Cynthia M Patton SVP & CCO |
BUY
Grant, award, or other acquisition
|
Direct |
3,527
+12.52%
|
-
|
Mar 07
2018
|
David Piacquad SVP, Business Development |
BUY
Grant, award, or other acquisition
|
Direct |
4,031
+9.71%
|
-
|
Mar 07
2018
|
Esteban Santos EVP, Operations |
BUY
Grant, award, or other acquisition
|
Direct |
3,527
+9.16%
|
-
|
Feb 14
2018
|
Sean E Harper EVP, Research & Development |
SELL
Open market or private sale
|
Direct |
1,525
-2.84%
|
$265,350
$174.18 P/Share
|
Feb 07
2018
|
Lori A Johnston EVP, HR |
SELL
Payment of exercise price or tax liability
|
Direct |
441
-2.85%
|
$77,616
$176.65 P/Share
|
Feb 06
2018
|
Wanda M Austin Director |
BUY
Grant, award, or other acquisition
|
Direct |
94
+50.0%
|
-
|
Jan 31
2018
|
Robert A Bradway Chairman, CEO and President |
SELL
Payment of exercise price or tax liability
|
Direct |
2,616
-0.66%
|
$499,656
$191.27 P/Share
|
Jan 31
2018
|
Sean E Harper EVP, Research & Development |
SELL
Payment of exercise price or tax liability
|
Direct |
606
-1.12%
|
$115,746
$191.27 P/Share
|
Jan 31
2018
|
Anthony C Hooper EVP, Global Commercial Ops. |
SELL
Payment of exercise price or tax liability
|
Direct |
651
-0.32%
|
$124,341
$191.27 P/Share
|
Jan 31
2018
|
Cynthia M Patton SVP & CCO |
SELL
Payment of exercise price or tax liability
|
Direct |
132
-0.62%
|
$25,212
$191.27 P/Share
|
Jan 31
2018
|
Esteban Santos EVP, Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
141
-0.45%
|
$26,931
$191.27 P/Share
|
Jan 30
2018
|
Robert A Bradway Chairman, CEO and President |
SELL
Payment of exercise price or tax liability
|
Direct |
1,533
-0.39%
|
$303,534
$198.0 P/Share
|
Jan 30
2018
|
Sean E Harper EVP, Research & Development |
SELL
Payment of exercise price or tax liability
|
Direct |
453
-0.83%
|
$89,694
$198.0 P/Share
|
Jan 30
2018
|
Anthony C Hooper EVP, Global Commercial Ops. |
SELL
Payment of exercise price or tax liability
|
Direct |
575
-0.28%
|
$113,850
$198.0 P/Share
|
Jan 30
2018
|
Cynthia M Patton SVP & CCO |
SELL
Payment of exercise price or tax liability
|
Direct |
109
-0.51%
|
$21,582
$198.0 P/Share
|
Jan 30
2018
|
Esteban Santos EVP, Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
133
-0.42%
|
$26,334
$198.0 P/Share
|
Jan 30
2018
|
David W Meline EVP & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
496
-1.03%
|
$98,208
$198.0 P/Share
|
Jan 30
2018
|
David Piacquad SVP, Business Development |
SELL
Payment of exercise price or tax liability
|
Direct |
153
-0.46%
|
$30,294
$198.0 P/Share
|
Jan 16
2018
|
Sean E Harper EVP, Research & Development |
SELL
Open market or private sale
|
Direct |
1,525
-2.71%
|
$282,125
$185.62 P/Share
|
Dec 12
2017
|
Sean E Harper EVP, Research & Development |
SELL
Open market or private sale
|
Direct |
1,525
-2.65%
|
$268,400
$176.83 P/Share
|
Nov 13
2017
|
Sean E Harper EVP, Research & Development |
SELL
Open market or private sale
|
Direct |
1,525
-2.58%
|
$260,775
$171.58 P/Share
|
Nov 08
2017
|
Francois De Carbonnel Director |
SELL
Open market or private sale
|
Direct |
4,000
-20.48%
|
$692,000
$173.61 P/Share
|
Oct 09
2017
|
Sean E Harper EVP, Research & Development |
SELL
Open market or private sale
|
Direct |
1,525
-2.51%
|
$282,125
$185.95 P/Share
|
Aug 04
2017
|
Jonathan P Graham EVP & Gen. Counsel & Secy. |
SELL
Payment of exercise price or tax liability
|
Direct |
6,747
-13.25%
|
$1,173,978
$174.18 P/Share
|
Aug 02
2017
|
Esteban Santos EVP, Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
639
-1.99%
|
$111,186
$174.13 P/Share
|
Aug 01
2017
|
David W Meline EVP & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
7,562
-13.63%
|
$1,315,788
$174.51 P/Share
|
May 31
2017
|
David Baltimore Director |
SELL
Open market or private sale
|
Direct |
3,700
-10.61%
|
$566,100
$153.93 P/Share
|
May 24
2017
|
Cynthia M Patton SVP & CCO |
SELL
Open market or private sale
|
Direct |
2,922
-12.07%
|
$449,988
$154.4 P/Share
|
May 24
2017
|
Cynthia M Patton SVP & CCO |
SELL
Bona fide gift
|
Direct |
346
-1.41%
|
-
|
May 01
2017
|
David Baltimore Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,230
+3.41%
|
-
|